Reports
Reports
Sale
The market is driven by factors such as the rising prevalence of food allergies among children and adults. Due to the increasing prevalence, research institutes and key players in the market are expanding their sources and focusing on developing the best treatment for food-allergic patients across the 7 major markets. The continuous development of innovative solutions in the market can result in increased adoption as a major population is suffering from a common food allergy, especially to peanuts. This innovative technology and its increased adoption are also expected to trigger research and development activities to find solutions for other food allergies including tree nuts, propelling the food allergy market growth.
Additionally, a new research and innovation project is targeting the development of novel immunotherapeutic drugs for peanut and multiple tree nut allergies. The project is a collaboration between DTU National Food Institute, The Hospital for Sick Children (SickKids) in Canada, and the pharmaceutical company ALK. The project ALLEVIATE2 will complete the preclinical development of sublingual immunotherapy drug candidates for the treatment of peanut allergy first. If this goes well and happens to be successful, the project will subsequently apply the same therapeutic approach and develop new treatments for tree nut allergies as well. This project has been funded with 18.5 million DKK (Danish Krone) by the Innovation Fund Denmark.
Innovations and research activities in the field of food allergies have been driving the market growth due to the limited treatment options available in the. These efforts from researchers and institutes can assist pharmaceutical and biotechnology companies in developing new treatments that can improve the quality of life for food allergy patients, further boosting the market.
Food Allergy Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Food Allergy Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Food Allergy Epidemiology Analysis – 7MM
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Food Allergy Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Food Allergy Epidemiology Forecast (2017-2032)
5.3.1 Germany Food Allergy Epidemiology Forecast (2017-2032)
5.3.2 France Food Allergy Epidemiology Forecast (2017-2032)
5.3.3 Italy Food Allergy Epidemiology Forecast (2017-2032)
5.3.4 Spain Food Allergy Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Food Allergy Epidemiology Forecast (2017-2032)
5.4 Japan Food Allergy Epidemiology Forecast (2017-2032)
6 Food Allergy Market Overview – 7MM
6.1 Food Allergy Market Historical Value (2017-2023)
6.2 Food Allergy Market Forecast Value (2024-2032)
7 Food Allergy Market Landscape – 7MM
7.1 Food Allergy Therapeutics Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Food Allergy Therapeutics Product Landscape
7.2.1 Analysis by Products
7.2.2 Analysis by Indications
7.2.3 Analysis by Route of Administration
8 Food Allergy Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Food Allergy Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Food Allergy Market Segmentation – 7MM
11.1 Food Allergy Market by Food Source
11.1.1 Market Overview
11.1.2 Dairy Products
11.1.3 Poultry Product
11.1.4 Tree Nuts
11.1.5 Peanuts
11.1.6 Shellfish
11.1.7 Wheat
11.1.8 Soy
11.1.9 Others
11.2 Food Allergy Market by Symptoms
11.2.1 Market Overview
11.2.2 Anaphylaxis
11.2.3 Atopic Dermatitis
11.2.4 Others
11.3 Food Allergy Market by Diagnosis Test
11.3.1 Skin-Prick Tests
11.3.2 Blood Test
11.3.3 Elimination Diet
11.3.4 Oral Food Challenge
11.3.5 Others
11.4 Food Allergy Market by Treatment Type
11.4.1 Market Overview
11.4.2 Epinephrine
11.4.3 Oral Immunotherapy
11.4.4 Antihistamines
11.4.5 Others
11.5 Food Allergy Market by Region
11.5.1 Market Overview
11.5.2 United States
11.5.3 EU-4 and the United Kingdom
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 Italy
11.5.3.4 Spain
11.5.3.5 United Kingdom
11.5.4 Japan
12 United States Food Allergy Market
12.1 Food Allergy Market Historical Value (2017-2023)
12.2 Food Allergy Market Forecast Value (2024-2032)
12.3 Food Allergy Market by Disease Type
12.4 Food Allergy Market by Treatment Type
13 EU-4 and United Kingdom Food Allergy Market
13.1 Food Allergy Market Historical Value (2017-2023)
13.2 Food Allergy Market Forecast Value (2024-2032)
13.3 Germany Food Allergy Market Overview
13.3.1 Food Allergy Market by Disease Type
13.3.2 Food Allergy Market by Treatment Type
13.4 France Food Allergy Market Overview
13.4.1 Food Allergy Market by Disease Type
13.4.2 Food Allergy Market by Treatment Type
13.5 Italy Food Allergy Market Overview
13.5.1 Food Allergy Market by Disease Type
13.5.2 Food Allergy Market by Treatment Type
13.6 Spain Food Allergy Market Overview
13.6.1 Food Allergy Market by Disease Type
13.6.2 Food Allergy Market by Treatment Type
13.7 United Kingdom Food Allergy Market Overview
13.7.1 Food Allergy Market by Disease Type
13.7.2 Food Allergy Market by Treatment Type
14 Japan Food Allergy Market
14.1 Food Allergy Market Historical Value (2017-2023)
14.2 Food Allergy Market Forecast Value (2024-2032)
14.2.1 Food Allergy Market by Disease Type
14.2.2 Food Allergy Market by Treatment Type
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Grants Analysis
16.1 Analysis by year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Application
16.5 Analysis by Funding Institute
16.6 Analysis by NIH Departments
16.7 Analysis by Recipient Organization
17 Clinical Trials Analysis
17.1 Analysis by Trial Registration Year
17.2 Analysis by Trial Status
17.3 Analysis by Trial Phase
17.4 Analysis by Therapeutic Area
17.5 Analysis by Geography
18 Funding Analysis
18.1 Analysis by Funding Instances
18.2 Analysis by Type of Funding
18.3 Analysis by Funding Amount
18.4 Analysis by Leading Players
18.5 Analysis by Leading Investors
18.6 Analysis by Geography
19 Partnership and Collaborations Analysis
19.1 Analysis by Partnership Instances
19.2 Analysis by Type of Partnership
19.3 Analysis by Leading Players
19.4 Analysis by Geography
20 Supplier Landscape
20.1 Pfizer Inc.
20.1.1 Financial Analysis
20.1.2 Product Portfolio
20.1.3 Demographic Reach and Achievements
20.1.4 Mergers and Acquisition
20.1.5 Certifications
20.2 GlaxoSmithKline plc
20.2.1 Financial Analysis
20.2.2 Product Portfolio
20.2.3 Demographic Reach and Achievements
20.2.4 Mergers and Acquisition
20.2.5 Certifications
20.3 Novartis AG
20.3.1 Financial Analysis
20.3.2 Product Portfolio
20.3.3 Demographic Reach and Achievements
20.3.4 Mergers and Acquisition
20.3.5 Certifications
20.4 Mylan N.V.
20.4.1 Financial Analysis
20.4.2 Product Portfolio
20.4.3 Demographic Reach and Achievements
20.4.4 Mergers and Acquisition
20.4.5 Certifications
20.5 Teva Pharmaceutical Industries
20.5.1 Financial Analysis
20.5.2 Product Portfolio
20.5.3 Demographic Reach and Achievements
20.5.4 Mergers and Acquisition
20.5.5 Certifications
20.6 Sanofi
20.6.1 Financial Analysis
20.6.2 Product Portfolio
20.6.3 Demographic Reach and Achievements
20.6.4 Mergers and Acquisition
20.6.5 Certifications
20.7 Boehringer Ingelheim International GmbH
20.7.1 Financial Analysis
20.7.2 Product Portfolio
20.7.3 Demographic Reach and Achievements
20.7.4 Mergers and Acquisition
20.7.5 Certifications
20.8 AstraZeneca
20.8.1 Financial Analysis
20.8.2 Product Portfolio
20.8.3 Demographic Reach and Achievements
20.8.4 Mergers and Acquisition
20.8.5 Certifications
20.9 Johnson & Johnson Private Limited
20.9.1 Financial Analysis
20.9.2 Product Portfolio
20.9.3 Demographic Reach and Achievements
20.9.4 Mergers and Acquisition
20.9.5 Certifications
20.10 Bayer AG
20.10.1 Financial Analysis
20.10.2 Product Portfolio
20.10.3 Demographic Reach and Achievements
20.10.4 Mergers and Acquisition
20.10.5 Certifications
21 Food Allergy Market - Distribution Model (Additional Insight)
21.1 Overview
21.2 Potential Distributors
21.3 Key Parameters for Distribution Partner Assessment
22 Key Opinion Leaders (KOL) Insights (Additional Insight)
23 Company Competitiveness Analysis (Additional Insight)
23.1 Very Small Companies
23.2 Small Companies
23.3 Mid-Sized Companies
23.4 Large Companies
23.5 Very Large Companies
24 Payment Methods (Additional Insight)
24.1 Government Funded
24.2 Private Insurance
24.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 39.03 billion in 2023, driven by the increase in food allergies among people.
The market is anticipated to grow at a CAGR of 5.40% during the forecast period of 2024-2032 and is likely to reach a market value of USD 62.7 billion by 2032.
The increasing incidence of food allergies and increased awareness among people are the major factors driving the market growth.
Increased research and development activities are among the major trends influencing market growth.
The major regions of the market include the United States, Japan, EU-4 and the United Kingdom.
Food allergies can be caused by dairy products, poultry products, tree nuts, peanuts, shellfish, wheat, and soy, among others.
Symptoms of food allergies include anaphylaxis and atopic dermatitis, among others.
Tests include skin-prick tests, blood tests, elimination diet, and oral food challenges, among others.
Epinephrine, oral immunotherapy, and antihistamines, among others are some treatments used to treat food allergies.
Key players involved in the market are Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Sanofi, Boehringer Ingelheim International GmbH, AstraZeneca, Johnson & Johnson Private Limited, and Bayer AG.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.